Novartis Singapore steps up in the race to net-zero | Singapore EDB
Leveraging innovation and a strong culture of sustainability, Novartis Singapore Pharmaceutical Manufacturing (NSPM) aims to cross the significant milestone of carbon neutrality for Scope 1 and 2 emissions at its Tuas facility.